Clinical Trial Update: Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating routine therapy plus moxifloxacin in advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Advanced Breast Cancer, Antibiotic | Phase 2 | Status: COMPLETED